Overview

Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer

Status:
Completed

Trial end date:
2020-09-23

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the clinical benefit and safety of Apatinib plus Best Supportive Care in comparison to Placebo plus Best Supportive Care in patients with advanced or metastatic gastric cancer

Phase:

Phase 3

Details

Lead Sponsor:

Elevar Therapeutics
LSK BioPartners Inc.

Treatments:

Apatinib